Corneal nerve and nerve conduction abnormalities in children with type 1 diabetes
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd..
OBJECTIVE: In vivo corneal confocal microscopy (CCM) is a novel, rapid, and non-invasive technique that identifies early small fiber damage and can predict the progression and development of clinical neuropathy in adults with type 1 diabetes. However, its usefulness in children is not well established. This study compared corneal confocal microscopy with neuropathic symptoms, signs, and objective measures of neuropathy for the diagnosis of diabetic neuropathy in children with type 1 diabetes.
RESEARCH DESIGN AND METHODS: A total of 83 children with type 1 diabetes and 83 healthy participants of similar age underwent assessment of neuropathy symptoms, signs, nerve conduction studies, quantitative sensory and autonomic function testing, and in vivo CCM.
RESULTS: Only of 3/83 (4%) children with type 1 diabetes had subclinical neuropathy. However, corneal nerve fiber density (p = 0.001), branch density (p = 0.006), fiber length (p = 0.002), tibial motor nerve amplitude and conduction velocity, and sural sensory nerve amplitude and conduction velocity (all p < 0.004) were lower in participants with type 1 diabetes than in the controls. Vibration, cooling, and warm perception thresholds and deep breathing heart rate variability were not found to be different (all p > 0.05) between children with type 1 diabetes and healthy controls. Multivariate regression analysis identified a possible association between body mass index and decreased corneal nerves.
CONCLUSIONS: Decreased corneal nerves and abnormal nerve conduction were found in children with type 1 diabetes. CCM may allow rapid objective detection of subclinical diabetic neuropathy in children and adolescents with type 1 diabetes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Pediatric diabetes - 23(2022), 8 vom: 22. Dez., Seite 1665-1673 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pacaud, Danièle [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adolescents |
|---|
| Anmerkungen: |
Date Completed 21.12.2022 Date Revised 28.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/pedi.13419 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM346476496 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM346476496 | ||
| 003 | DE-627 | ||
| 005 | 20231226031542.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/pedi.13419 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1154.xml |
| 035 | |a (DE-627)NLM346476496 | ||
| 035 | |a (NLM)36131228 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pacaud, Danièle |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Corneal nerve and nerve conduction abnormalities in children with type 1 diabetes |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.12.2022 | ||
| 500 | |a Date Revised 28.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. | ||
| 520 | |a OBJECTIVE: In vivo corneal confocal microscopy (CCM) is a novel, rapid, and non-invasive technique that identifies early small fiber damage and can predict the progression and development of clinical neuropathy in adults with type 1 diabetes. However, its usefulness in children is not well established. This study compared corneal confocal microscopy with neuropathic symptoms, signs, and objective measures of neuropathy for the diagnosis of diabetic neuropathy in children with type 1 diabetes | ||
| 520 | |a RESEARCH DESIGN AND METHODS: A total of 83 children with type 1 diabetes and 83 healthy participants of similar age underwent assessment of neuropathy symptoms, signs, nerve conduction studies, quantitative sensory and autonomic function testing, and in vivo CCM | ||
| 520 | |a RESULTS: Only of 3/83 (4%) children with type 1 diabetes had subclinical neuropathy. However, corneal nerve fiber density (p = 0.001), branch density (p = 0.006), fiber length (p = 0.002), tibial motor nerve amplitude and conduction velocity, and sural sensory nerve amplitude and conduction velocity (all p < 0.004) were lower in participants with type 1 diabetes than in the controls. Vibration, cooling, and warm perception thresholds and deep breathing heart rate variability were not found to be different (all p > 0.05) between children with type 1 diabetes and healthy controls. Multivariate regression analysis identified a possible association between body mass index and decreased corneal nerves | ||
| 520 | |a CONCLUSIONS: Decreased corneal nerves and abnormal nerve conduction were found in children with type 1 diabetes. CCM may allow rapid objective detection of subclinical diabetic neuropathy in children and adolescents with type 1 diabetes | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a adolescents | |
| 650 | 4 | |a children | |
| 650 | 4 | |a corneal confocal microscopy | |
| 650 | 4 | |a diabetic neuropathy | |
| 650 | 4 | |a neurophysiology | |
| 650 | 4 | |a type 1 diabetes | |
| 700 | 1 | |a Romanchuk, Kenneth G |e verfasserin |4 aut | |
| 700 | 1 | |a Virtanen, Heidi |e verfasserin |4 aut | |
| 700 | 1 | |a Ferdousi, Maryam |e verfasserin |4 aut | |
| 700 | 1 | |a Nettel-Aguirre, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Mah, Jean K |e verfasserin |4 aut | |
| 700 | 1 | |a Tavakoli, Mitra |e verfasserin |4 aut | |
| 700 | 1 | |a Zochodne, Douglas W |e verfasserin |4 aut | |
| 700 | 1 | |a Malik, Rayaz A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pediatric diabetes |d 2000 |g 23(2022), 8 vom: 22. Dez., Seite 1665-1673 |w (DE-627)NLM14370222X |x 1399-5448 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2022 |g number:8 |g day:22 |g month:12 |g pages:1665-1673 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/pedi.13419 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2022 |e 8 |b 22 |c 12 |h 1665-1673 | ||